President Biden’s recent Executive Order on artificial intelligence (AI) ushers in noteworthy developments for the health and life science sector. This Order delineates tasks for federal agencies, including those charged with overseeing the health industry, mandating them to establish responsible AI guidelines and cogent measures to regulate and assess its application.
While the primary emphasis of the Order might seem to be governmental buy-in regarding AI usage, its impact will resonate throughout the health and life science industry. Federal agencies assigned with health industry oversight duties are directed to incorporate accountable AI practices in their operations. These federally-developed guidelines are expected to set rigorous standards for AI applications within the broader industry.
The AI Executive Order delineates two key areas for health and life science industry stakeholders to monitor.
- Agencies will focus on creating policies that facilitate ‘AI-ready’ environments in the federal government. This means introducing AI technologies into existing processes and preparing personnel for a more tech-advanced workplace.
- Agencies are to provide direction on the regulatory approach for AI applications in the private sector. This will likely include discussions about best ethical practices and determining how these might translate into regulatory requirements.
Despite the Executive Order addressing a broad range of AI applications, healthcare organizations stand to benefit significantly. These directives signal a shift in regulatory approach, implying a more supportive environment for the deployment and use of AI in healthcare.
The new guidelines should foster advances in patient care, predictive modeling, and proactive healthcare delivery, among other potential benefits. As such, reflecting on the forthcoming changes and understanding their implications becomes crucial for healthcare providers, insurers, and other industry stakeholders.
With this pivotal shift, participating legal professionals will also need to remain vigilant, updating and adjusting their strategies in lockstep with the evolving guidelines and regulations.